NOVEL CRYSTALLINE FORMS OF SUGAMMADEX
The present disclosure provides novel crystalline forms of sugammadex, designated herein as crystalline fonn Type 7 of sugammadex, crystalline form Type 10 of sugammadex, crystalline form Type 12 of sugammadex, and crystalline fonn Type 13 of sugammadex, pharmaceutical compositions thereof, and meth...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present disclosure provides novel crystalline forms of sugammadex, designated herein as crystalline fonn Type 7 of sugammadex, crystalline form Type 10 of sugammadex, crystalline form Type 12 of sugammadex, and crystalline fonn Type 13 of sugammadex, pharmaceutical compositions thereof, and methods for their use in the reversal of neuromuscular blockade induced by rocuronium bromide or by vecuronium bromide in adults undergoing surgery. |
|---|